Gilead Sciences and Merck are collaborating on Phase 3 oral HIV regimen trials.
2 reports, 2 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gilead Sciences and Merck are collaborating on Phase 3 oral HIV regimen trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gilead Sciences
company in Madrid, Spain
Nothing else this week.
-
Merck
public company in Indonesia